UK-based sales software providers Highspot and Cognism both scored funding in late-stage rounds, with Salesforce Ventures, Axa Venture Partners and Swisscom Ventures among the investors.

OSF HealthCare’s corporate venturing unit inaugurated its largest fund to date, following the close of $75m funds in 2016 and 2019.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Rush University Medical Center is among the backers of Transcarent’s series C round, which pushed the company’s overall financing to $298m.

The diagnostics technology developer has raised another $290m from existing investor Roche, which will support it as it looks to expand its products to additional cancers.

Synthetic DNA producer DNA Script and personalised health plan provider Transcarent each closed $200m corporate-backed series C rounds.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Business-focused neobank Qonto raised $552m from investors including Tencent at a $552m valuation while SK provided $350m for Center for CDMO Breakthrough Medicines.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Eikon Therapeutics was co-founded by UC Berkeley researchers, one of whom has already received a Nobel Prize for the underlying technology.